Past President
Professor Joseph Doyle
FRACP FAFPHM

Professor Doyle is a clinician-researcher and dual-trained infectious diseases and public health physician. He has a special interest in the epidemiology, management and prevention of blood-borne viruses and emerging infections. Joe is Professor of Infectious Diseases at The Alfred and Monash University, and Deputy Director of Disease Elimination Program at the Burnet Institute. He leads a multi-disciplinary research group focused on communicable diseases of clinical fellows, PhD students, nurses, social researchers and public health practitioners. Joe has led national and global guidelines development including for the National Clinical Evidence Taskforce and the World Health Organization. He has advised government through COVID19 response and the statutory Independent Pandemic Management Advisory Committee in Victoria. He serves on the Communicable Diseases Network of Australia and Pharmaceutical Benefits Advisory Committee of the Australian Government.

Treasurer
Dr Rekha Pai Mangalore
FRACP

Dr Rekha Pai Mangalore is an Infectious Diseases physician with experience working across public and private sectors. Her PhD research will result in the implementation of a beta-lactam therapeutic drug monitoring program at Alfred Health, Melbourne and the development of a Bayesian software precision dosing program with an overall goal of improving precision in the management of infectious diseases. Dr Mangalore is committed to addressing the prevalence of inequity, gender and racial bias; and is an advocate for change, mentoring and supporting others, and amplifying diverse voices whenever possible. She is an Infectious Diseases Advanced trainee (RACP) supervisor and mentor; and also supports and mentors medical students, particularly those from overseas and from diverse backgrounds.

Dr Nigel Raymond
FRACP

Dr Raymond is an Infectious Diseases & General Physician at Capital & Coast (Wellington), Te Whatu Ora. He is an Honorary Clinical Senior Lecturer, University of Otago, and an IPC advisor for Evolution Healthcare, Wellington. He has chaired the New Zealand ASID Committee, 2017 – 2023. During the COVID-19 pandemic he chaired the Ministry’s COVID-19 Therapeutics technical advisory group (TAG) and was a member of the national COVID-19 TAG. He is a member of PHARMAC’s COVID-19 Treatments Advisory Group. His recent research interests include sepsis and COVID-19. Dr Raymond is an advocate for the advancement of infection services, including with the Ministry of Health and Te Whatu Ora (Health NZ) following recent NZ Health reforms.

Dr Annaleise Howard-Jones
FRACP FRCPA

Dr Annaleise Howard-Jones is a Paediatric Infectious Diseases Physician and Clinical Microbiologist at The Children’s Hospital at Westmead in New South Wales. She is a Senior Clinical Lecturer at The University of Sydney with research interests in emerging infections, clinical genomics and antimicrobial resistance, and experience spanning multidisciplinary liaison, implementation science, governance and curriculum development.

Dr Irene Kourtis - CEO
PhD, GAICD, GDIP IP Law

Irene has a background in microbiology, having completed a PhD in Virology at the Burnet Institute and previously worked at the Victorian Infectious Diseases Reference Laboratory. Irene has held a variety of leadership positions across health, life sciences, and member organisations. She has helped establish the International Forensic and Clinical Toxicology Association, which represents clinicians, scientists, and other members. Executive appointments include CEO of Neuroscience Trials Australia, a niche CRO delivering Phase I to III clinical trials, AGRF - The Australian Genome Research Facility and former Executive/COO at ATSE. Irene is an NED and consults and mentors startups across the MEDtech space.

President
Professor Chris Blyth
FRACP FRCPA FAHMS

Professor Chris Blyth is a Paediatric Infectious Diseases Physician at Perth Children’s Hospital and Clinical Microbiologist with PathWest Laboratory WA. Chris is head of the Wesfarmers Centre of Vaccine and Infectious Disease, The Kids Research Institute Australia and Professor within the School of Medicine, University of Western Australia where the multidisciplinary research group he leads undertakes basic, clinical and applied research focusing on the treatment and prevention of childhood infection, particularly acute respiratory infections. He has a particular interest in vaccine programs and policy, sepsis and antimicrobial resistance. He was a member of the Australian Technical Advisory Group on Immunisation (ATAGI) from 2012 and co-chair from 2018-2021, member of the Communicable Disease Network of Australia (CDNA) for the Australian Government and chair of the Western Australian Immunisation Advisory Committee (WAIAC).

Professor Ben Marais
FRACP

Professor Marais is a Paediatric Infectious Diseases Physician at the Westmead Children’s Hospital. He is also the acting Director of the Sydney Infectious Diseases Institute (Sydney ID). He held consecutive NHMRC Career Development and Practitioner Fellowships. His research focuses primarily on strategies to reduce the global tuberculosis (TB) disease burden, how children are affected by the TB pandemic and the spread of drug resistant TB. He co-leads the WHO Collaborating Centre in Tuberculosis at the University of Sydney and the NHMRC Centre for Research Excellence in Tuberculosis. He serves on the National TB Advisory Committee (NTAC) and is deputy-Chair of the WHO/STOP-TB Partnership Child and Adolescent TB working group.

Dr Candice Holland
FRACP FAFPHM‍ ‍

Dr Candice Holland is a dual-trained Infectious Diseases and Public Health Physician working for West Moreton Health and Metro North Health in Brisbane, including the Queensland Statewide Syphilis Register. She is a Senior Lecturer with the University of Queensland. Dr Holland held public health leadership positions with the Queensland Department of Health Communicable Diseases Branch, with contributions to responses to Communicable Diseases Incidents of National Significance for COVID-19, Japanese encephalitis virus and mpox. Dr Holland is currently Co-chair of the ASID Advocacy and Policy Committee and the National Q Fever interest group (QFIG). She has particular interest in communicable diseases prevention and control, AMR policy, vaccine preventable diseases, BBVSTIs, prisoner health, One Health and sustainable healthcare.

Prof Jason Trubiano
FRACP, FAAAAI‍ ‍

Professor Trubiano is an Infectious Diseases Physician, Director of Infectious Diseases at Austin Health and Head of the Department of Infectious Diseases in the Melbourne Medical School. He is an NHMRC Emerging Leadership Fellow at the University of Melbourne, Department of Infectious Diseases. He is the laboratory head for the Centre for Antibiotic Allergy and Research (Austin Health) and his research explores health services programs for antibiotic allergy and novel diagnostics and pharmacogenomic predictors for severe T-cell mediated drug reactions.